2023-08-02 13:41:55 ET
- Alnylam Pharmaceuticals ( NASDAQ: ALNY ) is scheduled to announce Q2 earnings results on Thursday, August 3rd, before market open.
- The consensus EPS Estimate is -$1.34 (+34.0% Y/Y) and the consensus Revenue Estimate is $350.57M (+55.9% Y/Y).
- Over the last 2 years, ALNY has beaten EPS estimates 25% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 6 upward revisions and 2 downward. Revenue estimates have seen 8 upward revisions and 8 downward.
For further details see:
Alnylam Pharmaceuticals Q2 2023 Earnings Preview